Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States

Overview of attention for article published in BMC Gastroenterology, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 1 news story.

Am J Manag Care. 2020;26:S220-S226. https://doi.org/10.37765/ajmc.2020.88513 Introduction Liver cancer is the most rapidly…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.